Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1987-07-10
1989-07-25
Howard, Jacqueline V.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514557, 514960, 514962, 514947, A61K 3119
Patent
active
048514446
ABSTRACT:
Onset-hastened and enhanced analgesic response is elicited in a mammalian organism in need of such treatment, i.e., a mammal suffering pain, by administering thereto a unit dosage onset-hastening/enhancing analgesically effective amount of the S(+) ibuprofen enantiomer, said enantiomer being substantially free of its R(-) ibuprofen antipode.
REFERENCES:
patent: 4555524 (1985-11-01), Gruber et al.
patent: 4690823 (1987-09-01), Lohner et al.
Biochemical Pharmacology, vol. 35, No. 19 (Oct. 1986), pp. 3403-3405, Pergamon Journals Ltd., K. Williams et al., "The Steroselective Uptake of Ibuprofen Enantiomers into Adipose Tissue".
Current Medical Research and Opinion, vol. 3, No. 8 (1975), p. 552, S. S. Adams et al., "The Optical Isomers of Ibuprofen".
J. Pharm. Pharmacol., vol. 28 (1976), pp. 256-257, S. S. Adams et al., "Pharmacological Difference Between the Optical Isomers of Ibuprofen: Evidence for Metabolic Inversion of the (-)--Isomer".
Journal of Pharmaceutical Sciences, vol. 56 (1967), p. 1686, S. S. Adams et al., "Some Biological Properties of 2--(4--Isobutylphenyl)--Propionic Acid".
Biochemical and Biophysical Research Communications, bol. 61, No. 3 (1974), pp. 833-837, W. J. Wechter et al., "Enzymatic Inversion at Saturated Carbon: Nature and Mechanism of the Inversion of R(-) p--iso--Butyl Hydratropic Acid".
J. Pharm. Pharmacol., vol. 35 (1983), pp. 693-704, Andrew J. Hutt et al., "The Metabolic Chiral Inversion of 2--Arylpropionic Acids--A Noval Route with Pharmacological Consequences".
Clinical Pharmacokinetics, vol. 9 (1984), pp. 371-373, Andrew J. Hutt et al., "The Importance of Stereo-Chemistry in the Clinical Pharmacokinetics of the 2-Arylproprionic Acid Non-Steroidal Anti-Inflammatory Drugs".
The Journal of Pharmacology and Experimental Therapeutics, vol. 232, No. 3 (1985), pp. 636-643, J. W. Cox et al., "Ibuprofen Stereoisomer Hepatic Clearance and Distribution in Normal and Fatty in Situ Perfused Rat Liver".
Clinical Pharmacology & Therapeutics, vol. 41, No. 2 (Feb. 1987), p. 200.
Clinical Pharmacology & Therapeutics, vol. 40, No. 1 (1986), pp 1-7, Eugene M. Laska et al., "The Correlation Between Blood Levels of Ibuprofen and Clinical Analgesic Response".
Chemical Abstracts, vol. 106 (1987), Abstract No. 66922r (Daicel Chemical Industries, Ltd.).
Physicians' Desk Reference, 40th Edition (1986), pp. 1854-1855, Edward R. Barnhart.
Xenobiotica, vol. 3, No. 9 (1973), pp. 589-598, R. F. N. Mills et al., "The Metabolism of Ibuprofen".
Journal of Pharmaceutical Sciences, vol. 64, No. 5 (1975), pp. 798-801, Garrett J. Vangiessen et al., "GLC Determination of Ibuprofen [dl-2-(p-Isobutylphenyl)Propionic Acid] Enantiomers in Biological Specimens".
Journal of Pharmaceutical Science, vol. 65, No. 2 (Feb. 1976), pp. 269-273, D. G. Kaiser et al., "Isomeric Inversion of Ibuprofen (R)-Enantiomer in Humans".
Anti-Inflammatory and Anti-Rheumatic Drugs, Eds. Rainsford and Path, CRC Press Inc., Boca Raton, Fla. (1985), p. 172, Anthony C. Allison et al., "Naproxen".
Angew. Chem. Internat. Edit., vol. 11, No. 6 (1972), pp. 460-472, T. Y. Shen, "Perspectives in Nonsteroidal Anti-Inflammatory Agents".
Nonsteroidal Anti-Inflammatory Agents, Chapter 62 in Burger's Medical Chemistry, 4th Edition, Part III, Wiley Interscience, New York (1981), pp. 1205-1271, T. Y. Shen.
Br. J. Clin. Pharmac., vol. 19 (1985), pp. 669-674, E. J. D. Lee et al., "Stereoselective Disposition of Ibuprofen Enantiomers in Man".
The Journal of Pharmacology and Experimental Therapeutics, vol. 148, No. 3 (1965), pp. 373-379, Charles A. Winder et al., "Nociceptive Thresholds as Affected by Parenteral Administration of Irritants and of Various Antinociceptive Drugs".
Proceedings of the Society for Experimental Biology and Medicine, vol. 118, (1965), pp. 763-766. H. Blumberg et al., "Use of Writhing Test for Evaluating Analgesic Activity of Narcotic Antagonists".
Journal of Pharmaceutical Sciences, vol. 73, No. 11 (Nov. 1984), pp. 1542-1544, E. J. D. Lee et al., American Pharmaceutical Association, "Liquid Chromatographic Determination and Plasma Concentration Profile of Optical Isomers of Ibuprofen in Humans".
Remington's Pharmaceutical Sciences, 15th Edition (1975), Mack Publishing Company, Easton, Pennsylvania 18042, Chapter 59, p. 1054, John E. Hoover.
Caldwell et al., "The Metabolic Chiral Inversion and Dispositional Enantioselectivity of the 2-Arylpropionic Acids and Their Biological Consequences", vol. 37, No. 1, pp. 105-114 (1988).
Laska Eugene M.
Sunshine Abraham
Analgesic Associates
Howard Jacqueline V.
LandOfFree
Onset-hastened/enhanced analgesia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Onset-hastened/enhanced analgesia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Onset-hastened/enhanced analgesia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2358643